Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -0.19% vs 0.28% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -9.11% vs -8.98% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is -8.36% vs 3.26% in Mar 2025
Compare Balance Sheet Results of Norris Medicines
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.93
6.00
3.93
65.50%
Share Warrants & Outstandings
Total Reserve
-25.07
23.17
-48.24
-208.20%
Shareholder's Funds
-15.15
29.17
-44.32
-151.94%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
18.51
0.00
18.51
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
18.51
0.00
18.51
0.00%
Deferred Tax Assets / Liabilities
-0.90
-1.35
0.45
33.33%
Other Long Term Liabilities
0.00
0.10
-0.10
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.83
-0.83
-100.00%
Total Non-Current Liabilities
17.61
-0.42
18.03
4,292.86%
Current Liabilities
Trade Payables
2.62
23.10
-20.48
-88.66%
Other Current Liabilities
1.16
8.83
-7.67
-86.86%
Short Term Borrowings
3.02
0.01
3.01
30,100.00%
Short Term Provisions
2.72
6.14
-3.42
-55.70%
Total Current Liabilities
9.53
38.08
-28.55
-74.97%
Total Liabilities
11.99
66.84
-54.85
-82.06%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.77
1.76
26.01
1,477.84%
Less: Accumulated Depreciation
22.98
1.28
21.70
1,695.31%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
4.79
0.48
4.31
897.92%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.01
3.46
-3.45
-99.71%
Long Term Loans & Advances
1.38
1.05
0.33
31.43%
Other Non Current Assets
0.00
3.00
-3.00
-100.00%
Total Non-Current Assets
6.17
8.10
-1.93
-23.83%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
3.98
4.00
-0.02
-0.50%
Sundry Debtors
1.17
29.94
-28.77
-96.09%
Cash and Bank
0.02
5.71
-5.69
-99.65%
Other Current Assets
0.63
13.65
-13.02
-95.38%
Short Term Loans and Advances
0.00
5.44
-5.44
-100.00%
Total Current Assets
5.81
58.74
-52.93
-90.11%
Net Current Assets (Including Current Investments)
-3.71
20.66
-24.37
-117.96%
Total Current Assets Excluding Current Investments
5.81
58.74
-52.93
-90.11%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
11.99
66.84
-54.85
-82.06%
Contingent Liabilities
1.33
0.00
1.33
0.00%
Total Debt
21.54
0.01
21.53
215,300.00%
Book Value per share (adjusted)
-15.26
48.62
-63.88
-131.39%
Annual - Borrowings
Borrowings 21.54 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -0.19% vs 0.28% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 4.79 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -9.11% vs -8.98% in Mar 2025
Annual - Investments
Investments 0.01 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 5.81 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -8.36% vs 3.26% in Mar 2025
